Previous Article | Next Article ![]()
J. Bacteriol., Apr 1997, 2274-2280, Vol 179, No. 7
R Edgar and E Bibi
Multidrug resistance (MDR) translocators recently identified in bacteria
constitute an excellent model system for studying the MDR phenomenon and
its clinical relevance. Here we describe the identification and
characterization of an unusual MDR gene (mdfA) from Escherichia coli. mdfA
encodes a putative membrane protein (MdfA) of 410 amino acid residues which
belongs to the major facilitator superfamily of transport proteins. Cells
expressing MdfA from a multicopy plasmid are substantially more resistant
to a diverse group of cationic or zwitterionic lipophilic compounds such as
ethidium bromide, tetraphenylphosphonium, rhodamine, daunomycin,
benzalkonium, rifampin, tetracycline, and puromycin. Surprisingly, however,
MdfA also confers resistance to chemically unrelated, clinically important
antibiotics such as chloramphenicol, erythromycin, and certain
aminoglycosides and fluoroquinolones. Transport experiments with an E. coli
strain lacking F1-F0 proton ATPase activity indicate that MdfA is a
multidrug transporter that is driven by the proton electrochemical
gradient.
Copyright © 1997, American Society for Microbiology
MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition
Department of Biochemistry, Weizmann Institute of Science, Rehovot, Israel.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»